Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal antibody to human Nogo-A protein of the IgG4/kappa class

EU orphan designation number: EU/3/08/605   
Active ingredient: Recombinant human monoclonal antibody to human Nogo-A protein of the IgG4/kappa class
Indication: Treatment of spinal cord injury
Sponsor: Novartis Europharm Limited
Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2009 Orphan designation EMEA/OD/059/08 (2009)387 of 19/01/2009
29/08/2014 Change of name and/or address of sponsor
16/05/2018 Transfer of orphan designation EMEA/OD/059/08/T/01 (2018)3035 of 8/05/2018